TrialClinical and experimental nephrology2021

A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.

Naoki Kashihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.